VivaChek Biotech
Hangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Develops rapid point-of-care diagnostic tests for infectious diseases.
Infectious Disease
Technology Platform
A lateral flow immunoassay (LFIA) platform optimized for high-sensitivity, rapid, point-of-care detection of infectious disease biomarkers.
Opportunities
Growing global emphasis on infectious disease surveillance and home testing creates expanding demand for its rapid diagnostic solutions.
Risk Factors
Low barriers to entry for simple lateral flow tests lead to intense price competition and margin pressure.
Competitive Landscape
Competes on price and distribution in the crowded rapid diagnostic test market against larger global and domestic players.